DJIA 17,619.51 23.16 0.13%
NASDAQ 4,986.87 28.40 0.57%
S&P 500 2,063.11 5.47 0.27%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)

company name or ticker

Sarepta Files Eteplirsen NDA, Secures $40M Debt Financing - Analyst Blog

BioMarin's NDA for DMD Drug Drisapersen Accepted by FDA - Analyst Blog

5 Biotech Stocks On Deck With The FDA

Today's Dead Cat Bounce Stock Is Sarepta Therapeutics (SRPT)

The Drug Development Process Explained in Detail and How It Impacts Your Investments

A detailed step-by-step guide on how a drug goes from a concept in the lab to a product on pharmacy shelves, and how the drug development process can affect your investments.

Premarket Biotech Digest: Celgene-Juno, AbbVie Rx Data, FDA-Gilead Lawsuit

The Reason Behind Sarepta Therapeutics Inc.'s Sinking Stock Price

Sarepta Therapeutics shares tumble after the company makes two important corporate announcements.

Sarepta Takes Its Foot Off the Gas

Sell The News In Sarepta Therapeutics

Benzinga's Top #PreMarket Gainers

See More Articles...